Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Evolocumab in in Combination With Statin Therapy in Adults With Ischemic Stroke

NCT05697185 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Guangxi Medical University as lead sponsor.

NCT NCT05697185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05697185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Evolocumab in in Combination With Statin Therapy in Adults With Ischemic Stroke
Lead sponsor
Second Affiliated Hospital of Guangxi Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
February 1, 2023
Completion date
December 1, 2024
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, acute